Clinical Trials on Hepatitis, Viral, Human

Total 21720 results

Janssen Scientific Affairs, LLC

Completed

An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver Transplant (GALAXY)

Hepatitits C

United States
Chinese University of Hong Kong

Completed

An Open-label Trial of 48-week Peginterferon Alfa-2a (PEGASYS) to Assess the Sustained Response of Chronic Hepatitis B Patients With HBeAg Seroconversion on Nucleot(s)Ide Analogue Therapy

Chronic Hepaititis B

Hong Kong
Alios Biopharma Inc.
Janssen Pharmaceutica

Terminated

First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C

Chronic Hepatitits C

Georgia, Moldova, Republic of, France
Chinese University of Hong Kong

Completed

Seroepidemiology of Viral Hepatitis in Hong Kong

Viral Hepatitis

China
University Health Network, Toronto

Completed

The Role of FGL2-FcgammaRIIB Inhibitory Pathway in Human Viral Hepatitis

Chronic Hepatitis C Infection

Canada
Hannover Medical School
Gilead Sciences; HepNet Study House, German Liverfoundation; German Center for...

Completed

HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)

Hepatitis E | Hepatitis Chronic Viral

Germany
University Health Network, Toronto

Terminated

Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)

Hepatitis C Viral Infection

Canada
The Immunobiological Technology Institute (Bio-Manguinhos)...

Completed

Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy Volunteers

Chronic Viral Hepatitis C

Brazil
Hong Ren

Recruiting

A Clinical Research on Disease Progression and Intervention of Chronic HepatitisB

Hepatitis B, Chronic

China
Central Hospital, Nancy, France

Unknown

Hepatitis E Infection : Emergence Mechanisms in North-Eastern France of Polymorphic Clinical Forms. (VHENE)

Hepatitis E Infection in Humans and in Environment

France
ANRS, Emerging Infectious Diseases
Bristol-Myers Squibb; Merck Sharp & Dohme LLC; Gilead Sciences; Roche Pharma AG; Janssen-Cilag...

Active, not recruiting

Therapeutic Option for Hepatitis B and C: a French Cohort (HEPATHER)

Viral Hepatitis C | Viral Hepatitis B

France
University of Dundee

Active, not recruiting

Evaluating Treatment as Prevention Among People Who Inject Drugs in Dundee for HCV (ERAPID HCV)

Hepatitis C Viral

United Kingdom
Austral University, Argentina

Unknown

Re-linkage to Care of Patients With Hepatitis C

Viral Hepatitis C

Argentina
Eiger BioPharmaceuticals

Completed

Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a (D-LIVR)

Hepatitis Delta Virus

United States, Belgium, Spain, Greece, Canada, Italy, Romania, Germany, Israel, Bulgaria, Taiwan, Turkey, Pakistan, Sweden, Ukraine, New Zealand, Russian Federation, United Kingdom, Moldova, Republic of, France, Mongolia, Switzerland
ANRS, Emerging Infectious Diseases

Completed

DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) (DRIVE-C)

Hepatitis C | Viral Hepatitis C | Drug Use

Vietnam
Pham Ngoc Thach University of Medicine

Enrolling by invitation

Continuing Medical Education to Improve Knowledge of Viral Hepatitis B-C in Primary Healthcare Workers

Viral Hepatitis

Vietnam
Hepatera Ltd.

Completed

Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent

Chronic Viral Hepatitis B With Delta-agent

Russian Federation
Asan Medical Center
Samsung Medical Center; Seoul National University Hospital; Korea University... and other collaborators

Completed

Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B (IN-US-0205)

Chronic Viral Hepatitis B Without Delta-agent

Korea, Republic of
University Hospital, Limoges

Recruiting

DELTA DESCRIBE: the French Collaborative Project (DELTADESCRIBE)

Hepatitis D

France
International Vaccine Institute
Bill and Melinda Gates Foundation; Thrasher Research Fund; Open Philanthropy

Not yet recruiting

Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women

Hepatitis E Infection

Pakistan
National Center for Gastroentestinal and Liver...

Completed

Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B Virus

Hepatitis B | Hepatitis D | Viral Hepatitis

Sudan
French National Agency for Research on AIDS and...
Gilead Sciences; Pharmasset

Terminated

ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB Therapy

HBe Negative Chronic Hepatitis B | Hepatitis B Viral Infection

France
Trek Therapeutics, PBC

Completed

A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection

Chronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral Infection

United States, New Zealand
Trek Therapeutics, PBC

Completed

A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection

Chronic Hepatitis C | Hepatitis C (HCV) | Hepatitis C Genotype 4 | Hepatitis C Viral Infection

United States
Asan Medical Center
Samsung Medical Center; Seoul National University Hospital; Korea University... and other collaborators

Completed

Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B (IN-US-0202)

Chronic Viral Hepatitis B Without Delta-agent

Korea, Republic of
Asan Medical Center

Completed

Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B (TERESA)

Chronic Viral Hepatitis B Without Delta-agent

Korea, Republic of
F-star Therapeutics, Inc.

Completed

A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV (ACHIEVE)

Hepatitis B | Hepatitis, Viral

Canada, Hong Kong, Korea, Republic of, Taiwan
Eiger BioPharmaceuticals

Withdrawn

A Study of Lonafarnib With or Without Ritonavir in Patients With HDV (LOWR-5)

Chronic Delta Hepatitis
University of Bari

Completed

Autoantibodies and Direct-acting Antivirals (BIOEPA)

Viral Hepatitis C | Therapy Adverse Effect

Italy
Cairo University

Completed

Oral Microbiome of Patients With Hepatitis C Virus Infection

Hepatitis C Viral

Egypt
Massachusetts General Hospital

Withdrawn

Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers

Viral Hepatitis C

United States
Ziv Hospital
Hillel Yafe MC Hadera

Completed

Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?

Chronic Hepatitis C Viral Infection

Israel
Vital Therapies, Inc.

Completed

Safety & Efficacy of the Extracorporeal Liver Assist Device (ELAD) System in Patients With Hepatic Insufficiency (ELAD)

Chronic Hepatitis | Acute Hepatitis

United States
Eiger BioPharmaceuticals

Completed

Lonafarnib With and Without Ritonavir in HDV (LOWR-1) (LOWR-1)

Chronic Hepatitis D Infection

Turkey
Rockefeller University
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination

Hepatitis C

United States
AHS Cancer Control Alberta

Not yet recruiting

Steroid Sparing in Immune Related Hepatitis (irH)

Hepatitis Immune
National Taiwan University Hospital
AbbVie

Completed

PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis (PIVOTAL)

Hepatitis Viruses

Taiwan
Boryung Pharmaceutical Co., Ltd

Completed

To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-C)

Hepatitis A Vaccine

Korea, Republic of
French National Agency for Research on AIDS and...

Completed

Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders (ANRS VITAVIC)

Chronic Hepatitis C

France
Alios Biopharma Inc.

Terminated

Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers

Hepatitis B | Chronic Hepatitis B | Viral Hepatitis B

New Zealand
Boryung Pharmaceutical Co., Ltd

Completed

To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A)

Hepatitis A Vaccine

Korea, Republic of
Sinovac Biotech Co., Ltd
Liaoning Center for Disease Control and Prevention

Active, not recruiting

Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old

Hepatitis A

China
Centers for Disease Control and Prevention
University of Michigan; Ministry of Health, Kazakhstan

Completed

A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A

Hepatitis A

Kazakhstan
GlaxoSmithKline

Completed

Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age

Hepatitis A

United States
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule

Hepatitis A

Belgium
GlaxoSmithKline

Withdrawn

Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel

Hepatitis A
GlaxoSmithKline

Completed

Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule

Hepatitis A

Belgium
Rijnstate Hospital

Completed

Hepatitis A Vaccination in the Elderly

Hepatitis A

Netherlands
Jiangsu Province Centers for Disease Control and...
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Completed

Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines

Hepatitis A

China
Ain Shams University

Completed

The Effects of Honey, as a Dietary Supplement in Children With Hepatitis A

Hepatitis A

Clinical Trials on Hepatitis, Viral, Human

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations